EmailHospital Circular 25/2007
Date issued: 17 December 2007
Distribution: Public hospitals
Subject: Highly Specialised Drugs Program
Purpose: To advise hospitals of changes to the Highly Specialised Drugs Program, effective 1 January 2008
We have had recent advice from the Commonwealth Government of changes to the Highly Specialised Drugs Program, effective 1 January 2008.
Added items
| Efavirenz | |||||
| 9618F | 200mg Tablet | 90 | Stocrin | $271.58 | MK |
Treatment of HIV infection in patients with:
- CD4 counts of less than 500 per cubic millimetre; or
- viral load greater than 10,000 copies per mL.
Full prescribing criteria for all items available at the Commonwealth/State Highly Specialised Drugs Program Guidelines website.
Advance Notice - Delete Item
| Efavirenz | ||||
| 6283Q | 200mg Capsule | 90 | Stocrin | MK |
Full prescribing criteria for all items available at the Commonwealth/State Highly Specialised Drugs Program Guidelines website.
Changes notified by hospital circular will be updated in the Guidelines on the Commonwealth/State Highly Specialised Drugs Program Guidelines website and the claim form amended.
Geoff Lavender
Director, Programs
Metropolitan Health & Aged Care Services
